A family of fatty acids including ALA, EPA and DHA; a generic mention does not identify the source or formulation.
Purpose, evidence and practical considerations.
Food intake, an over-the-counter supplement and a prescription triglyceride treatment are different contexts. Product labels must identify the fatty acids and their amounts before a study can be applied to that product.
Nutritional roles are established, but an unspecified omega-3 capsule cannot inherit the outcomes of a particular prescription EPA drug or fish-oil trial. Amount and chemical form must be known to assess a treatment claim.
Confidence: moderate
Supplements may cause gastrointestinal effects. High-dose EPA/DHA trials found increased atrial-fibrillation risk in cardiovascular-risk populations; anticoagulant use warrants review. These findings are not identical for every omega-3 form.
ALA is found in plant foods, while fish, krill and algae can supply EPA or DHA. These are related nutrients, but a report of “omega-3” does not identify which fatty acids or product were taken.
The evidence on this page does not automatically apply to:
How people use it, with their schedules, context and original sources.
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.